Lei Zhao Selected Research

Hepatocellular Carcinoma (Hepatoma)

4/2024	Neoadjuvant tislelizumab plus stereotactic body radiotherapy and adjuvant tislelizumab in early-stage resectable hepatocellular carcinoma: the Notable-HCC phase 1b trial.
1/2024	Achieving complete remission in metastatic hepatocellular carcinoma with sintilimab plus sorafenib therapy followed by hepatic resection: a case report.
12/2023	Inhibiting cholesterol de novo synthesis promotes hepatocellular carcinoma progression by upregulating prostaglandin E synthase 2-mediated arachidonic acid metabolism under high fatty acid conditions.
10/2023	Prognoses of Patients Treated With Surgical Therapy Versus Continuation of Local-Plus-Systemic Therapy Following Successful Down-Staging of Intermediate-Advanced Hepatocellular Carcinoma: A Multicenter Real-World Study.
10/2023	Enhancing the inhibition of cell proliferation and induction of apoptosis in H22 hepatoma cells through biotransformation of notoginsenoside R1 by Lactiplantibacillus plantarum S165 into 20(S/R)-notoginsenoside R2.
3/2023	LncRNA MBNL1-AS1 knockdown increases the sensitivity of hepatocellular carcinoma to tripterine by regulating miR-708-5p-mediated glycolysis.
11/2022	Corrigendum to "Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study" [Heliyon 8 (6) (2022) e09538].
6/2022	Lenvatinib plus sintilimab versus lenvatinib monotherapy as first-line treatment for advanced HBV-related hepatocellular carcinoma: A retrospective, real-world study.
5/2022	131I-Labeled Silk Fibroin Microspheres for Radioembolic Therapy of Rat Hepatocellular Carcinoma.
1/2022	FNDC5 Causes Resistance to Sorafenib by Activating the PI3K/Akt/Nrf2 Pathway in Hepatocellular Carcinoma Cells.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lei Zhao Research Topics

Disease

311	Neoplasms (Cancer) 05/2024 - 10/2006
133	Inflammation (Inflammations) 04/2024 - 09/2002
63	Neoplasm Metastasis (Metastasis) 01/2024 - 12/2004
61	Infections 03/2024 - 04/2007
55	Fibrosis (Cirrhosis) 04/2024 - 02/2013
37	Hepatocellular Carcinoma (Hepatoma) 04/2024 - 12/2004
34	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 09/2004
34	Esophageal Squamous Cell Carcinoma 11/2023 - 08/2012
34	Breast Neoplasms (Breast Cancer) 07/2023 - 06/2007
32	Carcinogenesis 10/2023 - 10/2009
32	Stomach Neoplasms (Stomach Cancer) 01/2023 - 03/2009
30	Insulin Resistance 04/2024 - 01/2009
30	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 03/2009
29	Heart Failure 04/2024 - 01/2009
28	Colorectal Neoplasms (Colorectal Cancer) 05/2024 - 01/2012
28	Atherosclerosis 08/2023 - 09/2002
27	Obesity 09/2023 - 01/2009
24	COVID-19 03/2024 - 01/2020
21	Non-alcoholic Fatty Liver Disease 05/2024 - 01/2009
21	Periodontitis 03/2024 - 02/2008
20	Type 2 Diabetes Mellitus (MODY) 04/2024 - 12/2005
20	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 12/2004
19	Hemorrhage 03/2024 - 01/2007
19	Carcinoma (Carcinomatosis) 01/2023 - 03/2009
18	Necrosis 01/2022 - 03/2006
17	Sepsis (Septicemia) 03/2024 - 05/2006
17	Stroke (Strokes) 02/2024 - 09/2004
16	Body Weight (Weight, Body) 12/2023 - 08/2011
16	Liver Cirrhosis (Hepatic Cirrhosis) 07/2023 - 10/2009
16	Hypoxia (Hypoxemia) 01/2023 - 12/2011
16	Brain Ischemia (Cerebral Ischemia) 01/2023 - 06/2008
15	Atrial Fibrillation 05/2024 - 01/2019
15	Wounds and Injuries (Trauma) 03/2024 - 03/2012
15	Ischemia 01/2023 - 06/2008
15	Pancreatic Neoplasms (Pancreatic Cancer) 01/2023 - 12/2009
14	Myocardial Infarction 11/2023 - 09/2004
13	Infarction (Infarctions) 03/2024 - 06/2008
13	Ischemic Stroke 02/2024 - 01/2015
13	Cognitive Dysfunction 10/2023 - 05/2010
13	Leukemia 10/2023 - 07/2010
13	Lung Neoplasms (Lung Cancer) 07/2023 - 03/2009
13	Reperfusion Injury 01/2020 - 06/2008
12	Pain (Aches) 04/2024 - 11/2006
12	Hypertension (High Blood Pressure) 01/2024 - 10/2009
12	Lymphoma (Lymphomas) 01/2023 - 04/2008
12	Esophageal Neoplasms (Esophageal Cancer) 01/2023 - 12/2013
12	Hyperuricemia 10/2022 - 01/2019
12	Colonic Neoplasms (Colon Cancer) 01/2022 - 10/2009
11	Virus Diseases (Viral Diseases) 03/2024 - 06/2014
11	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024 - 04/2009
11	Adenocarcinoma 11/2023 - 12/2011
11	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2015
10	Parkinson Disease (Parkinson's Disease) 02/2024 - 12/2007

Drug/Important Bio-Agent (IBA)

151	Proteins (Proteins, Gene)FDA Link 04/2024 - 01/2002
91	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2007
52	Messenger RNA (mRNA)IBA 02/2024 - 09/2002
43	MicroRNAs (MicroRNA)IBA 01/2024 - 05/2010
40	CytokinesIBA 01/2024 - 09/2002
33	Glucose (Dextrose)FDA LinkGeneric 04/2024 - 12/2005
33	Long Noncoding RNAIBA 02/2024 - 11/2015
31	LipidsIBA 04/2024 - 09/2004
28	LipopolysaccharidesIBA 03/2024 - 12/2005
27	EnzymesIBA 03/2024 - 07/2004
26	Therapeutic UsesIBA 04/2023 - 03/2009
25	Peptides (Polypeptides)IBA 04/2024 - 09/2002
25	Interleukin-6 (Interleukin 6)IBA 02/2023 - 05/2006
23	DNA (Deoxyribonucleic Acid)IBA 03/2024 - 04/2009
23	Immune Checkpoint InhibitorsIBA 02/2024 - 01/2020
21	CholesterolIBA 12/2023 - 01/2009
20	LigandsIBA 04/2024 - 07/2008
19	Phosphotransferases (Kinase)IBA 12/2020 - 07/2010
18	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 05/2006
17	Antiviral Agents (Antivirals)IBA 05/2022 - 11/2010
16	RNA (Ribonucleic Acid)IBA 05/2024 - 01/2011
15	Insulin (Novolin)FDA Link 04/2024 - 12/2005
15	Reactive Oxygen Species (Oxygen Radicals)IBA 03/2024 - 12/2006
15	Cisplatin (Platino)FDA LinkGeneric 03/2024 - 03/2010
15	Fatty Acids (Saturated Fatty Acids)IBA 12/2023 - 01/2014
15	CateninsIBA 12/2023 - 12/2018
15	InterleukinsIBA 06/2023 - 08/2007
15	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 03/2010
14	Monoclonal AntibodiesIBA 05/2024 - 06/2007
14	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2023 - 01/2014
14	corilaginIBA 01/2023 - 07/2008
13	AntioxidantsIBA 04/2024 - 12/2005
13	C-Reactive ProteinIBA 01/2021 - 02/2007
12	InflammasomesIBA 05/2024 - 06/2017
12	AntibodiesIBA 03/2024 - 04/2008
12	Circular RNAIBA 06/2023 - 01/2019
11	CollagenIBA 04/2024 - 02/2013
11	CreatinineIBA 04/2024 - 11/2011
11	Amyloid (Amyloid Fibrils)IBA 01/2020 - 05/2010
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2024 - 01/2013

Therapy/Procedure

133	Therapeutics 12/2024 - 12/2004
55	Drug Therapy (Chemotherapy) 02/2024 - 11/2006
30	Immunotherapy 02/2024 - 05/2016
22	Radiotherapy 07/2023 - 01/2013
17	Neoadjuvant Therapy 05/2024 - 08/2015
14	Chinese Traditional Medicine (Traditional Chinese Medicine) 12/2024 - 10/2013
13	Chemoradiotherapy 01/2023 - 01/2014